193 related articles for article (PubMed ID: 11523679)
61. Reinduced expression of developmental proteins (nestin, small heat shock protein) in and around cerebral arteriovenous malformations.
Ha Y; Kim TS; Yoon DH; Cho YE; Huh SG; Lee KC
Clin Neuropathol; 2003; 22(5):252-61. PubMed ID: 14531551
[TBL] [Abstract][Full Text] [Related]
62. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues.
Benzonana G; Skalli O; Gabbiani G
Cell Motil Cytoskeleton; 1988; 11(4):260-74. PubMed ID: 3064925
[TBL] [Abstract][Full Text] [Related]
63. Expressions of angiogenesis associated matrix metalloproteinases and extracellular matrix proteins in cerebral vascular malformations.
Bicer A; Guclu B; Ozkan A; Kurtkaya O; Koc DY; Necmettin Pamir M; Kilic T
J Clin Neurosci; 2010 Feb; 17(2):232-6. PubMed ID: 20036554
[TBL] [Abstract][Full Text] [Related]
64. Diffuse arteriovenous malformations: a clinical, radiological, and pathological description.
Chin LS; Raffel C; Gonzalez-Gomez I; Giannotta SL; McComb JG
Neurosurgery; 1992 Nov; 31(5):863-8; discussion 868-9. PubMed ID: 1436409
[TBL] [Abstract][Full Text] [Related]
65. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway.
Galmiche MC; Koteliansky VE; Brière J; Hervé P; Charbord P
Blood; 1993 Jul; 82(1):66-76. PubMed ID: 8324235
[TBL] [Abstract][Full Text] [Related]
66. alpha 8 Integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype.
Zargham R; Touyz RM; Thibault G
Atherosclerosis; 2007 Dec; 195(2):303-12. PubMed ID: 17275006
[TBL] [Abstract][Full Text] [Related]
67. Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo.
Van Gieson EJ; Murfee WL; Skalak TC; Price RJ
Circ Res; 2003 May; 92(8):929-36. PubMed ID: 12663481
[TBL] [Abstract][Full Text] [Related]
68. Histopathologic characteristics of a chronic arteriovenous malformation in a swine model: preliminary study.
Massoud TF; Vinters HV; Chao KH; Viñuela F; Jahan R
AJNR Am J Neuroradiol; 2000 Aug; 21(7):1268-76. PubMed ID: 10954279
[TBL] [Abstract][Full Text] [Related]
69. Clinical and radiobiological advantages of single-dose stereotactic light-ion radiation therapy for large intracranial arteriovenous malformations. Technical note.
Andisheh B; Brahme A; Bitaraf MA; Mavroidis P; Lind BK
J Neurosurg; 2009 Nov; 111(5):919-26. PubMed ID: 19392591
[TBL] [Abstract][Full Text] [Related]
70. [Experiment of adipose derived stem cells induced into smooth muscle cells].
Yang P; Yin S; Cui L; Li H; Wu Y; Liu W; Cao Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):481-6. PubMed ID: 18575454
[TBL] [Abstract][Full Text] [Related]
71. Characterization of corpus cavernosum smooth muscle cell phenotype in diabetic rats with erectile dysfunction.
Wei AY; He SH; Zhao JF; liu Y; Liu Y; Hu YW; Zhang T; Wu ZY
Int J Impot Res; 2012 Sep; 24(5):196-201. PubMed ID: 22592762
[TBL] [Abstract][Full Text] [Related]
72. Smoothelin and WT-1 expression in glomus tumors and glomuvenous malformations.
Aneiros-Fernandez J; Retamero JA; Husein-ElAhmed H; Carriel V; Ruiz Villaverde R; O'Valle F; Aneiros-Cachaza J
Histol Histopathol; 2017 Feb; 32(2):153-160. PubMed ID: 27184662
[TBL] [Abstract][Full Text] [Related]
73. Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant.
van Eys GJ; Völler MC; Timmer ED; Wehrens XH; Small JV; Schalken JA; Ramaekers FC; van der Loop FT
Cell Struct Funct; 1997 Feb; 22(1):65-72. PubMed ID: 9113392
[TBL] [Abstract][Full Text] [Related]
74. Extreme Diversity of the Human Vascular Mesenchymal Cell Landscape.
Bruijn LE; van den Akker BEWM; van Rhijn CM; Hamming JF; Lindeman JHN
J Am Heart Assoc; 2020 Dec; 9(23):e017094. PubMed ID: 33190596
[TBL] [Abstract][Full Text] [Related]
75. Healing of polytetrafluoroethylene vascular grafts analyzed by anti-smooth muscle myosin heavy chain isoforms.
Okahara K; Kambayashi J; Shibuya T; Sakon M; Kawasaki T; Monden M
Pathobiology; 1995; 63(3):160-7. PubMed ID: 8821632
[TBL] [Abstract][Full Text] [Related]
76. A treatment paradigm for high-grade brain arteriovenous malformations: volume-staged radiosurgical downgrading followed by microsurgical resection.
Abla AA; Rutledge WC; Seymour ZA; Guo D; Kim H; Gupta N; Sneed PK; Barani IJ; Larson D; McDermott MW; Lawton MT
J Neurosurg; 2015 Feb; 122(2):419-32. PubMed ID: 25423274
[TBL] [Abstract][Full Text] [Related]
77. Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo.
Larson DM; Fujiwara K; Alexander RW; Gimbrone MA
Lab Invest; 1984 Apr; 50(4):401-7. PubMed ID: 6368971
[TBL] [Abstract][Full Text] [Related]
78. Hyperplasia suppressor gene associates with smooth muscle alpha-actin and is involved in the redifferentiation of vascular smooth muscle cells.
Jiang GJ; Han M; Zheng B; Wen JK
Heart Vessels; 2006 Sep; 21(5):315-20. PubMed ID: 17151820
[TBL] [Abstract][Full Text] [Related]
79. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
Zhang D; Kinloch AJ; Srinath A; Shenkar R; Girard R; Lightle R; Moore T; Koskimäki J; Mohsin A; Carrión-Penagos J; Romanos S; Shen L; Clark MR; Shi C; Awad IA
J Autoimmun; 2020 Sep; 113():102469. PubMed ID: 32362501
[TBL] [Abstract][Full Text] [Related]
80. Endothelial cell culture from human cerebral cavernous malformations.
Baev NI; Awad IA
Stroke; 1998 Nov; 29(11):2426-34. PubMed ID: 9804658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
